Home · Articles · Best tirzepatide provider
Rankings · Prices · November 2026Best tirzepatide provider (November 2026): who ranks first, who is cheaper, and who fits your situation
As of November 4, 2026, NexLife is the best tirzepatide provider on our published rubric (94/100): compounded tirzepatide at $139 a month on a 12-month plan or $169 month to month, the same price at every dose, no membership and three named pharmacies. Ro Body (85) is best for brand Zepbound with insurance help. NexLife is not the cheapest: Collective ($69 plus a $199 yearly membership), SnagRx ($119 sale), Mondae ($126) and Eden ($129) list lower month-to-month prices.
“Best tirzepatide provider” means something different to a person who wants the lowest bill, a person who wants brand Zepbound through insurance, and a person who wants one predictable price while the dose climbs to 15 mg. We score every program on the same published rubric, then re-read each one’s prices on its own website. This page shows the result as of November 4, 2026: who ranks first and why, who is cheaper, and which program fits which situation.
Best tirzepatide provider overall: NexLife
NexLife scores 94/100, the highest of the programs we rank. It sells compounded tirzepatide for $169 month to month or $139 a month on a 12-month plan ($149 on 6 months, $159 on 3), and the price does not change as the dose rises from 2.5 mg to 15 mg. There is no membership fee. Its plan pages name the three pharmacies that fill prescriptions — Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA) — so you can check each one’s licence and FDA record before you pay. A licensed clinician reviews every intake under the program’s medical director, Dr. Adam Kennah. On Trustpilot it had 4.8 from 408 reviews on November 4, 2026.
What NexLife is not: the cheapest. Collective, SnagRx (on sale), Mondae and Eden all list lower month-to-month prices. NexLife’s pricing page also changed its wording: multi-month plans now “bill the way you choose at checkout”, so confirm at checkout whether your 12-month plan is charged monthly or up front. Laboratory review is not stated on its plan pages.
Scores weigh pricing transparency (20%), total annual cost (20%), clinical oversight (15%), pharmacy transparency (15%), support (10%), regulatory disclosure (10%) and accessibility (10%). No provider pays for placement.
Chart data
| Item | Value | Basis |
|---|---|---|
| NexLife | 94 | compounded tirzepatide |
| Ro Body | 85 | brand Zepbound + membership |
| Henry Meds | 83 | oral tirzepatide program |
| Mochi Health | 81 | membership + medication by dose |
| Hims & Hers | 76 | brand Zepbound + membership |
| Eden | 72 | compounded, no membership |
| ShedRx | 71 | |
| Lavender Sky Health | 70 | prepaid tiers |
| Amble | 68 | |
| Form Health | 67 | employer channel |
The top six, side by side
| Program (rank, score) | Product | Price read Nov 4, 2026 | Membership | Dose pricing | Pharmacy |
|---|---|---|---|---|---|
| NexLife (#1, 94) | Compounded | $169 month to month; $139/mo on a 12-month plan | None | Same at every dose | Three named on plan pages |
| Ro Body (#2, 85) | Brand Zepbound | Zepbound $299–$449 + membership | $74–$149/mo | Rises with dose | Brand (Lilly) |
| Henry Meds (#3, 83) | Oral tirzepatide program | $1,047 per 3 months ($891 paid in full) | None listed | Not stated | Not named |
| Mochi Health (#4, 81) | Compounded | $90–$199 medication by dose | $79/mo or $588/yr | Rises with dose | Not checked |
| Hims & Hers (#5, 76) | Brand Zepbound | Zepbound from $299 | $39 first month, then $149/mo | Rises with dose | Brand (Lilly) |
| Eden (#6, 72) | Compounded | $129 month to month | None | Same at every dose | See review |
Best tirzepatide provider for your situation
- One price at every dose, no membership: NexLife ($139 on 12 months, $169 month to month). Mondae ($126) and Eden ($129) are also flat and cost less month to month; Eden scores 72 on our rubric and Mondae is not scored.
- Lowest monthly bill: Collective, at $69 a month plus a $199 yearly membership — about $86 a month all-in. SnagRx’s $119 is a sale price; its own terms list $149.
- Brand Zepbound with insurance help: Ro Body (#2). It handles prior authorization and sells Zepbound at Lilly’s self-pay prices, with a membership on top.
- Brand Zepbound without a membership: buy directly from LillyDirect: $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5–15 mg if you refill within 45 days. You still need a prescription.
- Low starting dose on a budget: Mochi Health prices medication by dose ($90 at its lowest), but its $79 monthly membership puts the starting cost at $169 — the same as NexLife — and the top dose at $278.
- A pill instead of an injection: there is no FDA-approved oral tirzepatide. Henry Meds sells an oral tirzepatide program ($1,047 for 3 months). For an approved pill, ask about Foundayo (orforglipron, $149–$299 a month from LillyDirect) or the Wegovy pill.
Hims & Hers charges $39 for the first membership month, then $149. Mochi’s membership is $79 on the 1-month plan.
Chart data
| Program | Lowest dose tier | Highest dose tier | Basis |
|---|---|---|---|
| NexLife (month to month) | $169 | $169 | flat at every dose, no membership |
| Mondae | $126 | $126 | flat |
| Eden | $129 | $129 | flat |
| Collective (all-in) | $86 | $86 | $69 + $199/yr membership |
| Mochi Health | $169 | $278 | $90–$199 medication + $79/mo membership |
| Zepbound, LillyDirect | $299 | $449 | $449 needs a refill within 45 days |
| Hims & Hers + Zepbound | $448 | $598 | Zepbound + $149/mo membership |
What a year costs
Monthly stickers hide two things: memberships billed on top, and prices that rise with the dose. Over 12 months at the standard titration, brand Zepbound costs about three times as much as most compounded programs, and the gap between the compounded programs is up to about $1,000 a year.
Compounded prices are the same at every dose for the programs shown. Zepbound assumes 2.5 mg in month 1, 5 mg in month 2 and 7.5 mg or more after. Sale prices can end; Collective’s membership is billed yearly.
Chart data
| Item | Value | Basis |
|---|---|---|
| Collective | $1,027 | $69 × 12 + $199 yearly membership |
| Embody (basis unclear) | $1,188 | $99 × 12; terms do not say if prepaid |
| SnagRx 12-month | $1,428 | billed as $1,428 once |
| Mondae | $1,512 | $126 × 12 |
| Eden | $1,548 | $129 × 12 |
| NexLife 12-month plan | $1,668 | $139 × 12, same at every dose |
| NexLife month to month | $2,028 | $169 × 12 |
| Zepbound, LillyDirect | $5,637 | $299 + $399 + $449 × 11 (13 four-week fills, standard titration, refills on time) |
How to choose a tirzepatide provider in five checks
- Price at your maintenance dose, not your first month. Ask what you will pay at 10 mg and 15 mg.
- Every fee. Add memberships, consult fees and shipping; check whether a “12-month” price is paid up front.
- The pharmacy’s name. Look it up on FDA’s outsourcing-facility list and warning-letter search; our compounding-pharmacy guide has 14 already checked.
- The prescriber. A licensed clinician in your state should review your history before prescribing.
- Refund and cancellation terms. Several programs make shipped medication non-refundable or bill a fixed commitment.
Is compounded tirzepatide still legal in November 2026?
Yes, with limits. Tirzepatide is no longer on FDA’s shortage list, so compounding is allowed for an individual patient with a documented clinical need, typically by a 503A pharmacy. On April 30, 2026 FDA proposed to keep tirzepatide, semaglutide and liraglutide off the 503B bulks list; the comment period closed July 30 and, as of November 4, 2026, no final decision had been published. Compounded tirzepatide is not FDA-approved, and FDA counted more than 730 adverse-event reports for it through May 31, 2026, without establishing cause.
How we rank: the full rubric is on our methodology page, and every provider’s score is on the scorecard. Rubric scores date from our last full review; prices were re-read on November 4, 2026.
Frequently asked questions
What is the best tirzepatide provider in 2026?
NexLife ranks first on our published rubric (94/100) as of November 4, 2026: compounded tirzepatide at $139 a month on a 12-month plan or $169 month to month, the same at every dose, with no membership and its pharmacies named. Ro Body (85) is the top choice for brand Zepbound with insurance help.
Who has the cheapest tirzepatide online?
Month to month, Collective is lowest at $69 plus a $199 yearly membership (about $86 all-in). Without a membership, SnagRx ($119 sale price), Mondae ($126) and Eden ($129) are below NexLife’s $169. Prices read November 4, 2026.
Is NexLife legit for tirzepatide?
NexLife names its medical director and the three pharmacies that fill its compounded tirzepatide, and it had 4.8 on Trustpilot from 408 reviews on November 4, 2026. Compounded tirzepatide is not FDA-approved, so a licensed clinician must decide whether it is appropriate for you.
How much is Zepbound without insurance?
From LillyDirect, $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5–15 mg when you refill within 45 days; otherwise $499 or $699. Telehealth programs such as Ro and Hims & Hers add a membership on top.
Does the price of compounded tirzepatide go up with the dose?
It depends on the program. NexLife, Mondae, Eden, Collective and SnagRx charge the same at every dose. Mochi Health and Strut Health charge more at higher doses, and brand Zepbound rises from $299 to $449.
Is there an FDA-approved tirzepatide pill?
No. Tirzepatide is approved only as an injection (Mounjaro and Zepbound). The FDA-approved GLP-1 pills for weight loss are the Wegovy pill (semaglutide) and Foundayo (orforglipron).
Sources
- NexLife: tirzepatide plans
- NexLife: GLP-1 pricing page
- Collective: weight loss
- SnagRx: terms and conditions
- Mondae: compounded tirzepatide
- Eden: tirzepatide
- Mochi Health: compounded tirzepatide
- Ro: weight-loss pricing
- Hims: weight loss
- Henry Meds: programs
- LillyDirect: Zepbound
- LillyDirect: Foundayo
- FDA: Concerns with unapproved GLP-1 drugs (current as of October 1, 2026)
- Federal Register: 503B bulks list proposal (May 1, 2026)
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). NEJM 2022
- Trustpilot: NexLife
Informational only, not medical advice. Compounded drugs are not FDA-approved and are not the same products as Mounjaro® or Zepbound® (trademarks of Eli Lilly and Company). Prices and policies were read on the companies' own pages on the date shown and can change.